Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 2 diabetes currently treated with basal insulin (QWINT-3): a phase 3, randomised, non-inferiority trial
1. 系统已在2025-07-11 11:15:06对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/S0140-6736(25)01044-X
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S014067362501044X
其他信息:
出版社: Elsevier BV
作者: Athena Philis-Tsimikas; Richard M Bergenstal; Timothy S Bailey; Hideaki Jinnouchi; James R Thrasher; Liza Ilag; Jit Mitra; Kristen Syring; Rebecca J Threlkeld